The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension
Abstract
Macrophages are the primary cellular targets of bacterial lipopolysaccharide (LPS), but the role of macrophage‐derived cytokines in LPS‐induced septic shock is uncertain. Recent evidence indicates that activation of peripheral CB1 cannabinoid receptors contributes to hemorrhagic hypotension and that macrophage‐derived anandamide as well as unidentified platelet‐derived substances may be contributing factors. Here we demonstrate that rat platelets contain the endogenous cannabinoid 2‐arachidonyl glyceride (2‐AG), as identified by reverse phase high‐performance liquid chromatography, gas chromatography, and mass spectrometry, and that in vitro exposure of platelets to LPS (200 μg/ml) markedly increases 2‐AG levels. LPS‐stimulated, but not control, macrophages contain anandamide, which is undetectable in either control or LPS‐stimulated platelets. Prolonged hypotension and tachycardia are elicited in urethane‐anesthetized rats treated 1) with LPS (15 mg/kg i.v.); 2) with macrophages plus platelets isolated from 3 ml of blood from an LPS‐treated donor rat; or 3) with rat macrophages or 4) platelets preincubated in vitro with LPS (200 μg/ml). In all four cases, the hypotension but not the tachycardia is prevented by pretreatment of the recipient rat with the CB1 receptor antagonist SR141716A (3 mg/kg i.v.), which also inhibits the hypotensive response to anandamide or 2‐AG. The hypotension elicited by LPS‐treated macrophages or platelets remains unchanged in the absence of sympathetic tone or after blockade of nitric oxide synthase. These findings indicate that platelets and macrophages generate different endogenous cannabinoids, and that both 2‐AG and anandamide may be paracrine mediators of endotoxin‐induced hypotension via activation of vascular CB1 receptors.—Varga, K., Wagner, J. A., Bridgen, D. T., Kunos, G. Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension. FASEB J. 12, 1035–1044 (1998)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Sherry, B., & Cerami, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1269 · Cited by 432
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., & Di Marzo, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 369
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 358
Ishac, E. J. N., Jiang, L., Lake, K. D., Varga, K., Abood, M. E., & Kunos, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15639.x · Cited by 345
Self-citationHillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020631.x · Cited by 338
Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
Goparaju, S. K., Ueda, N., Yamaguchi, H., & Yamamoto, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01603-7 · Cited by 328
Dentener, M. A., Bazil, V, Von Asmuth, E. J., Ceska, M., & Buurman, W. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2885 · Cited by 318
Prescott, S. M., & Majerus, P. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33114-4 · Cited by 315
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 284
Self-citationBISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., PETROCELLIS, L. D., & MARZO, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 275
An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant
Randall, M. D., Alexander, S. P. H., Bennett, T., Boyd, E. A., Fry, J. R., Gardiner, S. M., Kemp, P. A., Mcculloch, A. I., & Kendall, D. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1766 · Cited by 261
Devane, W. A., & Axelrod, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6698 · Cited by 220
The microcirculation during endotoxemia
McCuskey, R. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00113-7 · Cited by 204
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
Varga, K., Lake, K., Martin, B. R., & Kunos, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00181-j · Cited by 201
Self-citationLake, K. D., Compton, D. R., Varga, K., Martin, B. R., & Kunos, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36714-x · Cited by 201
Self-citationMARZO, V. D., BISOGNO, T., SUGIURA, T., MELCK, D., & PETROCELLIS, L. D. (1998) · Biochemical Journal · doi:10.1042/bj3310015 · Cited by 199
Di MARZO, V., De PETROCELLIS, L., SEPE, N., & BUONO, A. (1996) · Biochemical Journal · doi:10.1042/bj3160977 · Cited by 196
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
Self-citationMechanism of the Hypotensive Action of Anandamide in Anesthetized Rats
Varga, K., Lake, K. D., Huangfu, D., Guyenet, P. G., & Kunos, G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.682 · Cited by 151
Self-citationLee, M., Yang, K. H., & Kaminski, N. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12097-1 · Cited by 144
Search for Sepsis Drugs Goes on Despite Past Failures
Stone, R. (1994) · Science · doi:10.1126/science.8153620 · Cited by 130
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
Plane, F., Holland, M., Waldron, G. J., Garland, C. J., & Boyle, J. P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701361 · Cited by 125
Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin
Ellis, E. F., Moore, S. F., & Willoughby, K. A. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.6.h1859 · Cited by 115
Soluble E-Selectin Levels in Sepsis and Critical Illness
Cummings, C., Sessler, C. N., Beall, L. D., FISHER, B. J., Best, A. M., & Fowler, A. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9509017 · Cited by 106
Pratt, P. F., Hillard, C. J., Edgemond, W. S., & Campbell, W. B. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.1.h375 · Cited by 105
Potentiation of anandamide hypotension by the transport inhibitor, AM404
Calignano, A., Rana, G. L., Beltramo, M., Makriyannis, A., & Piomelli, D. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01297-1 · Cited by 96
Stein, E. A., Fuller, S. A., Edgemond, W. S., & Campbell, W. B. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15683.x · Cited by 79
Malinowska, B., Godlewski, G., Bucher, B., & Schlicker, E. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005041 · Cited by 71
Halling, J. L., Hamill, D. R., Lei, M. G., & Morrison, D. C. (1992) · Infection and Immunity · doi:10.1128/iai.60.3.845-852.1992 · Cited by 43
Patrini, G., Sacerdote, P., Fuzio, D., Manfredi, B., & Parolaro, D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00149-5 · Cited by 28
Cited by
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…the use of cannabinoid receptor antagonists, including SR141716, AM281, AM251, and SR144528, also leads to survival benefits in endotoxic and septic shock or necrotizing pancreatitis (Varga et al., 1998; Smith et al., 2000, 2001; Cainazzo et al., 2002; Kadoi et al., 2005a,b; Matsuda et al., 2005).”
BackgroundInfluentialSelf-citationThe endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Metadata
- Authors
- Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1998-08
- Volume
- 12
- Issue
- 11
- Pages
- 1035-1044
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1918234784
- Cited by
- 410
- References
- 44
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.